These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2778721)

  • 1. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
    Nichols AI; D'Ambrosio R; Pyszczynski NA; Jusko WJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):963-70. PubMed ID: 2778721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and dynamics of (+/-)-verapamil in lean and obese Zucker rats.
    Todd EL; Abernethy DR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):642-7. PubMed ID: 3735134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen.
    Nichols AI; Jusko WJ
    J Pharmacokinet Biopharm; 1990 Jun; 18(3):189-208. PubMed ID: 1974305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline disposition in obese rats.
    Shum L; Jusko WJ
    J Pharmacol Exp Ther; 1984 Feb; 228(2):380-6. PubMed ID: 6694116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of indomethacin on the pharmacokinetics and pharmacodynamics of prednisolone in rats.
    Garg V; Jusko WJ
    J Pharm Sci; 1994 May; 83(5):747-50. PubMed ID: 7915309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
    Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
    Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ketoconazole on methylprednisolone pharmacokinetics and receptor/gene-mediated pharmacodynamics.
    Haughey DB; Jusko WJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):826-32. PubMed ID: 1941630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.
    Haughey DB; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Aug; 20(4):333-55. PubMed ID: 1362219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-mediated pharmacodynamics of prednisolone in the rat.
    Boudinot FD; D'Ambrosio R; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):469-93. PubMed ID: 2879901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients.
    Bowdle TA; Neal GD; Levy RH; Heimbach DM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):97-9. PubMed ID: 7359372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat.
    Corcoran GB; Salazar DE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):17-22. PubMed ID: 2913269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.
    Dvorchik BH; Damphousse D
    J Clin Pharmacol; 2005 Jan; 45(1):48-56. PubMed ID: 15601805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat.
    Corcoran GB; Wong BK
    J Pharmacol Exp Ther; 1987 Jun; 241(3):921-7. PubMed ID: 3598908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisolone disposition in obese men.
    Milsap RL; Plaisance KI; Jusko WJ
    Clin Pharmacol Ther; 1984 Dec; 36(6):824-31. PubMed ID: 6499362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overfed rat model that reproduces acetaminophen disposition in obese humans.
    Wong BK; U SW; Corcoran GB
    Drug Metab Dispos; 1986; 14(6):674-9. PubMed ID: 2877825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.